A Study to Evaluate the Efficacy and Safety of Pirfenidone With Novel Coronavirus Infection
Clinical trial NCT04282902 · UNKNOWN
Trial details
- NCT number
- NCT04282902
- Sponsor
- Huilan Zhang
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-04
- Primary completion
- 2020-04-30
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.